BlackRock Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$230M Sell
1,602,036
-92,859
-5% -$12.4M 0.27% 78
2016
Q3
$212M Buy
1,694,895
+77,499
+5% +$10M 0.26% 81
2016
Q2
$212M Buy
1,617,396
+170,338
+12% +$23.3M 0.27% 79
2016
Q1
$201M Buy
1,447,058
+35,033
+2% +$4.68M 0.26% 84
2015
Q4
$197M Buy
1,412,025
+48,258
+4% +$6.65M 0.25% 92
2015
Q3
$191M Sell
1,363,767
-10,871
-0.8% -$1.63M 0.26% 86
2015
Q2
$226M Buy
1,374,638
+36,303
+3% +$5.8M 0.28% 80
2015
Q1
$207M Buy
1,338,335
+852,341
+175% +$121M 0.27% 85
2014
Q4
$61.1M Buy
485,994
+3,894
+0.8% +$481K 0.08% 249
2014
Q3
$57.7M Sell
482,100
-13,231
-3% -$1.52M 0.08% 240
2014
Q2
$53.3M Buy
495,331
+43,703
+10% +$4.5M 0.07% 273
2014
Q1
$45M Sell
451,628
-7,364
-2% -$666K 0.07% 282
2013
Q4
$42.4M Sell
458,992
-54,953
-11% -$4.88M 0.06% 283
2013
Q3
$43M Buy
513,945
+5,696
+1% +$488K 0.07% 254
2013
Q2
$41.6M Buy
+508,249
New +$38M 0.07% 238

Other funds holding ELV

BlackRock Investment Management's ELV Position: Q4 2016 in Review

BlackRock Investment Management reduced its Elevance Health (ELV) stake by 5.5% in Q4 2016, selling an estimated $12.4M and leaving 1,602,036 shares worth $230M. The position accounts for 0.27% of the portfolio, ranked #78.

BlackRock Investment Management first reported a position in ELV in Q2 2013 and has held it in 15 quarters since. 783 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • BlackRock Investment Management held 1,602,036 shares of Elevance Health worth $230M as of Q4 2016.
  • BlackRock Investment Management sold 92,859 Elevance Health shares in Q4 2016, an estimated $12.4M.
  • Elevance Health made up 0.27% of BlackRock Investment Management's portfolio in Q4 2016, its #78 holding.
  • BlackRock Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 15 quarters since.
  • 783 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.